IMMUNOR AS

Operating

home - Immunor AS

Immunor AS is a Norwegian-based vaccine developer unlike any other. Building on comprehensively patented IP of unique elegance and power, Immunor AS is in

Handel, rådgivning, bioteknologisk forskning og utvikling, eie og forvalte aksjer og verdipapirer, delta i andre foretak og alt som har forbindelse med dette.

Handel, rådgivning, produksjon, bioteknologisk forskning og utvikling, eie og forvalte aksjer og verdipapirer, delta i andre foretak og alt som har forbindelse med dette.

Organization

CEO: AS
Andres Schjønhaug Susrud1982
Chairman of the board: BS
Birger Sørensen1955
Years since formation: 12 years; since Nov 13, 2014
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 553,705,360; 1 share class
Total number of shareholders: 35; 24 companies, 11 persons

Financials

Annual total result 2024: -1,394,736; NOK
Total equity 2024: -105,943; NOK

Last update: Dec 12, 2025

Locations

Company address
Gaustadalléen 21 0349 OSLO, Norge
Copied!
Postal address
c/o Bionor Holding AS Gaustadalléen 21 0349 OSLO, Norge
Copied!

Management

Management / administration

Name	Role	Shares
AS Andres Schjønhaug Susrud 1982	Managing Director/CEO	22.03 % indirectly

Board

Name	Role	Shares
BS Birger Sørensen 1955	Chairman	30.81 % indirectly
AA Aslak Aslaksen 1959	Board Member	2.97 % indirectly
DA Dag Arne Wivelstad 1962 Resigned	Board Member	3.29 % indirectly

Others

Name	Role	Shares
H HENKA REVISJON AS	Auditor	-
S SIPAK REGNSKAP OG ØKONOMI AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
BS Birger Sørensen 1955	Chairman	30.81 % indirectly
AS Andres Schjønhaug Susrud 1982	Managing Director/CEO	22.03 % indirectly
HS Helén Schjønhaug Susrud 1981	-	11.02 % indirectly
DA Dag Arne Wivelstad 1962	Board Member	3.29 % indirectly
AA Aslak Aslaksen 1959	Board Member	2.97 % indirectly
JM Jonny Marinius Sørensen 1956	-	1.35 % indirectly
RS Roy-Inge Sørensen 1965	-	1.35 % indirectly

Last update: May 13, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
S SCHJØSUS INVEST AS	Ordinary shares	183,009,643	33.05 %
K KAG AS	Ordinary shares	170,575,483	30.81 %
NC Nauclr Cecilia	Ordinary shares	72,707,891	13.13 %
W WIVEL INVEST AS	Ordinary shares	18,227,631	3.29 %
A A A HOLDING AS	Ordinary shares	16,427,629	2.97 %
G GRAFO AS	Ordinary shares	11,562,113	2.09 %
AP Ab Pharmavizer	Ordinary shares	10,500,000	1.9 %
J JS HOLDING AS	Ordinary shares	7,462,687	1.35 %
E ENDERA AS	Ordinary shares	7,462,687	1.35 %
J JAHATT AS Closed	Ordinary shares	6,818,028	1.23 %
J JAKOB HATTELAND HOLDING AS	Ordinary shares	6,043,310	1.09 %
J JAN INGE SAGEIE AS	Ordinary shares	5,000,000	0.9 %
KS Ken Sakai 1978	Ordinary shares	5,000,000	0.9 %
J JARAH INVEST AS	Ordinary shares	4,524,524	0.82 %
D DIGISTEP AS	Ordinary shares	4,000,000	0.72 %
A APEX CAPITAL AS	Ordinary shares	3,136,360	0.57 %
S SMERUD MEDICAL RESEARCH INTERNATIONAL AS	Ordinary shares	2,551,520	0.46 %
F FINNMIN EIENDOM AS	Ordinary shares	2,523,303	0.46 %
S SOLON EIENDOM AS	Ordinary shares	2,045,410	0.37 %
GU Gullstein Unni 1963	Ordinary shares	1,841,791	0.33 %
RG Red Glead Discovery Ab	Ordinary shares	1,729,316	0.31 %
M MALISE AS	Ordinary shares	1,551,804	0.28 %
C CHRISHØEG AS	Ordinary shares	1,551,804	0.28 %
T TRE E FINANS AS	Ordinary shares	1,503,134	0.27 %
R RM CONSULTANTS AS	Ordinary shares	1,200,000	0.22 %
DA Dag Anders Olausson 1954	Ordinary shares	1,052,936	0.19 %
A AROSA INVEST AS	Ordinary shares	853,561	0.15 %
B BLUE HORIZON AS	Ordinary shares	805,687	0.15 %
CB Christian Barfod Sigmond 1959	Ordinary shares	608,776	0.11 %
OL Ottar Larsen 1963	Ordinary shares	340,900	0.06 %
TI Tor Ingvald Skaane 1942	Ordinary shares	340,138	0.06 %
ØM Øystein Måseidvåg 1953	Ordinary shares	204,540	0.04 %
PS Per Sture Mork 1952	Ordinary shares	200,000	0.04 %
A ADIANTE AS	Ordinary shares	200,000	0.04 %
M MD INVESTMENTS AS	Ordinary shares	142,754	0.03 %

Shares owned by the IMMUNOR AS

Name	Share class	Total number of shares	Share
B BIONOR HOLDING AS	NO0010813736	16,350,000	35.87 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2021
Total operating income	0	0	305,043
Annual Total Result	-1,394,736	-417,741	-223,336
Total assets	403,696	53,205	176,599
Total liabilities	509,639	3,180,581	2,000,772
Total equity	-105,943	-3,127,376	-1,824,173

P&L

Year	2024	2023	2021
Total operating income	0	0	305,043
Total operating costs	1,328,316	172,295	567,114
Operating result	-1,328,316	-172,295	-262,071
Financial income/costs	-66,421	-245,446	38,735
Profit before tax	-1,394,736	-417,741	-223,336
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-1,394,736	-417,741	-223,336

Balance overview

Year	2024	2023	2021
Total fixed assets	36,216	36,216	126,600
Total current assets	367,480	16,989	49,999
Total assets	403,696	53,205	176,599
Short term debt	159,216	710,586	248,872
Long term debt	350,423	2,469,995	1,751,900
Total liabilities	509,639	3,180,581	2,000,772
Contributed capital	4,466,719	50,550	24,334
Retained earnings	-4,572,662	-3,177,927	-1,848,507
Total equity	-105,943	-3,127,376	-1,824,173
Total equity and liabilities	403,697	53,205	176,599

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

IMMUNOR AS914 405 920

IMMUNOR AS

Links

Organization

Ownership

Financials

Locations

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the IMMUNOR AS

Financials

Summary

P&L

Balance overview

Classification